0
March 30, 1979, Vol 241, No. 13 >
ARTICLE | March 30, 1979

Pulmonary Medicine FREE

William R. Barclay, MD
JAMA. 1979;241(13):1387-1388. doi:10.1001/jama.1979.03290390065043
Text Size: A A A
Published online
Article
References

In recent years advances in the field of pulmonary medicine have resulted either from more sophisticated techniques to measure pulmonary function or from the use of fiberoptics combined with radiology to visualize better and to perform selectively biopsies of lung tissue. These techniques have increased diagnostic accuracy and have led to clearer perceptions of the relationship between lung structure and function. However, in 1978 infectious disease problems commanded the attention of pulmonologists and resulted in the description of a newly recognized entity, Legionnaires' disease,1 and the marketing of a vaccine against a disease long recognized, pneumococcal pneumonia.2

Legionnaires' Disease  Legionnaires' disease, in which the primary organ of attack is the lung, was at first of uncertain origin. Several theories were proposed, including a bacterial infection, a virus infection, an allergic reaction, and a toxin,3 as possible causes. Finally McDade et al4 isolated the causative organism by

REFERENCES

1 +
Fraser DW, Tsai TR, Orenstein W, et al:  Legionnaires' disease: Description of an epidemic of pneumonia . N Engl J Med 297:1189-1203, 1977;.
2 +
 Pneumococcal vaccine . Med Lett Drugs Ther 20:13-14, 1978;.
3 +
Chen JR, Francisco RB, Miller TE:  Legionnaires' disease: Nickel levels . Science 196:906-908, 1977;.
4 +
McDade JE, Sheppard CC, Fraser DN, et al:  Legionnaires' disease: Isolation of a bacterium . N Engl J Med 297:1218-1220, 1977;.
5 +
Katz SM, Nash P:  The morphology of the Legionnaires' disease organism . Am J Pathol 90:701-722, 1978;.
6 +
 Isolater of organisms resembling Legionnaires' disease bacterium from sources . Morbidity Mortality Weekly Rep 27:283-285, 1978;.
7 +
 Isolation of organisms resembling Legionnaires' disease bacterium . Morbidity Mortality Weekly Rep 27:415-416, 1978;.
8 +
Glick TH, Gregg MB, Berman B, et al:  Pontiac fever: An epidemic of unknown etiology in a health department . Am J Epidemiol 107:149-160, 1978;.
9 +
Blackman JA, Hicklin MD, Chandler FW:  Legionnaires' disease . Arch Pathol Lab Med 102:337-343, 1978;.
10 +
Austrian R:  Prevention of pneumococcal infection by immunization with capsular polysaccharides of Streptococcus pneumoniae . J Infect Dis 136( (suppl 1) ):38-42, 1977;.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

1 +
Fraser DW, Tsai TR, Orenstein W, et al:  Legionnaires' disease: Description of an epidemic of pneumonia . N Engl J Med 297:1189-1203, 1977;.
2 +
 Pneumococcal vaccine . Med Lett Drugs Ther 20:13-14, 1978;.
3 +
Chen JR, Francisco RB, Miller TE:  Legionnaires' disease: Nickel levels . Science 196:906-908, 1977;.
4 +
McDade JE, Sheppard CC, Fraser DN, et al:  Legionnaires' disease: Isolation of a bacterium . N Engl J Med 297:1218-1220, 1977;.
5 +
Katz SM, Nash P:  The morphology of the Legionnaires' disease organism . Am J Pathol 90:701-722, 1978;.
6 +
 Isolater of organisms resembling Legionnaires' disease bacterium from sources . Morbidity Mortality Weekly Rep 27:283-285, 1978;.
7 +
 Isolation of organisms resembling Legionnaires' disease bacterium . Morbidity Mortality Weekly Rep 27:415-416, 1978;.
8 +
Glick TH, Gregg MB, Berman B, et al:  Pontiac fever: An epidemic of unknown etiology in a health department . Am J Epidemiol 107:149-160, 1978;.
9 +
Blackman JA, Hicklin MD, Chandler FW:  Legionnaires' disease . Arch Pathol Lab Med 102:337-343, 1978;.
10 +
Austrian R:  Prevention of pneumococcal infection by immunization with capsular polysaccharides of Streptococcus pneumoniae . J Infect Dis 136( (suppl 1) ):38-42, 1977;.

Letters

Submit a Letter
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general journals
BMJ 2010;341:c5893-c1494.
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

© 2012 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems